Brief: Crescita Therapeutics Receives First Shipments Of Pliaglis, Product Will Be Launched By U.S. Licensing Partner
29/03/2018 13:06
March 29 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS INC - FIRST SHIPMENTS OF PLIAGLIS
HAVE
NOW BEEN RECEIVED AND PRODUCT WILL BE LAUNCHED BY OUR U.S.
LICENSING PARTNER
Source text for Eikon: ID:nPnccd5D3a
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium